| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.0096 | 0.9 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |